Mesenteric traction syndrome or gut in distress

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 2, 2005, Pages 195-199

  Avgerinos, D V ^a   Theoharides, T C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD38; Chronic lymphocytic leukemia; NAD + glycohydrolase; NAD+ metabolism

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; AZATADINE; AZELASTINE; BRADYKININ; CHONDROITIN SULFATE; CIMETIDINE; CYPROHEPTADINE; DIMENTIDENE; FLAVONOID; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; NITRIC OXIDE; PROSTACYCLIN; PROTEOGLYCAN; QUERCETIN; RETINOIC ACID; SEROTONIN; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; DRUG MECHANISM; FLUSHING; HUMAN; HYPOTENSION; LAPAROSCOPIC SURGERY; MAST CELL; MESENTERIC TRACTION SYNDROME; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SURGICAL STRESS; SYMPTOMATOLOGY; TACHYCARDIA;

EID: 20444449738     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800202     Document Type: Review

References (39)

1. Duda D., W. Lorenz and I. Celik. 2002. Histamine release in mesenteric traction syndrome during abdominal aortic aneurysm surgery: prophylaxis with H1 and H2 antihistamines. Inflamm. Res. 51:495.
2. Seeling W., H. Heinrich and W. Oettinger. 1986. The eventration syndrome: prostacyclin liberation and acute hypoxemia due to eventration of the small intestine. Anaesthesist 35:738.
3. Dripps R.D., J.E. Eckenhoff and L.D. Vandam. 1982. The principles of safe practice. In Introduction to anesthesia. W.B. Saunders Philadelphia, p. 374.
4. Strunin L. 1980. The splanchnic, hepatic and portal circulations. The circulation in anaesthesia. In Applied Physiology and Pharmacology. C. Prys-Robers, ed. Blackwell Scientific Publications Oxford, p. 241.
5. Kaufman L. 1980. Anaesthesia for abdominal surgery. In General Anaesthesia. T.C. Gray, J.E. Utting and J.F. Nunn, ed. Butterworths London, p. 1431.
6. Batchelder B.M. and L.H. Cooperman. 1975. Effects of anesthetics on splanchnic circulation and metabolism. Surg. Clin. North. Am. 55:787.
7. Seltzer J.L., D.E. Ritter, M.A. Starsnic and A.T. Marr. 1985. The hemodynamic response to traction on the abdominal mesentery. Anesthesiology 63:96.
8. Gottlieb A., V.A. Skrinska, P. O'Hara, A.R. Boutros, M. Melia and G.J. Beck. 1989. The role of prostacyclin in the mesenteric traction syndrome during anesthesia for abdominal aortic reconstructive surgery. Ann. Surg. 209:363.
9. Seltzer J.L., M.E. Goldberg, G.E. Larijani, D.E. Ritter, M.A. Starsnic, G.L. Stahl and A.M. Lefer. 1988. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology 68:514.
10. Brinkmann A., C.F. Wolf, D. Berger, E. Kneitinger, B. Neumeister, M. Buchler, P. Radermacher, W. Seeling and M. Georgieff. 1996. Perioperative endotoxemia and bacterial translocation during major abdominal surgery: evidence for the protective effect of endogenous prostacyclin? Crit. Care Med. 24:1293.
11. Koyama K., I. Kaneko and K. Mori. 1995. The effect of indomethacin suppository in preventing mesenteric traction syndrome. Masui 44:1131.
12. Moss J. 1995. Muscle relaxants and histamine release. Acta Anaesthesiol. Scand. 106(S):7.
13. Lorenz W., D. Duda, W. Dick, H. Sitter and A. Doenicke. 1994. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet 343:933.
14. Akerstrom G. and B. Lisander. 1994. Antihistaminergic pretreatment prevents tissue extravasation of albumin from intra-abdominal trauma in rats. Acta Anaesthesiol. Scand. 38:569.
15. Cutz E., W. Chan, N.S. Track, A. Goth and S.I. Said. 1978. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 275:661.
16. Boesiger J., M. Tsai, M. Maurer, M. Yamaguchi, L.F. Brown, K.P. Claffey, H.F. Dvorak and S.J. Galli. 1998. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fce reptor I expression. J. Exp. Med. 188:1135.
17. 206. Mol. Biol. Cell 9:875.
18. Bueno L., M.J. Fargeas, V. Theodorou and J. Fioramonti. 1991. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats. Eur. J. Pharmacol. 192:263.
19. Theoharides T.C., P.K. Bondy, N.D. Tsakalos and P.W. Askenase. 1982. Differential release of serotonin and histamine from mast cells. Nature 297:229.
20. Kandere-Grzybowska K., R. Letourneau, W. Boucher, J. Bery, D. Kempuraj, S. Poplawski, A. Athanassiou and T.C. Theoharides. 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171:4830.
21. Enerbäck L. 1963. Serotonin in human mast cells. Nature 117:610.
22. Theoharides T.C., R. Letourneau, P. Patra, L. Hesse, X. Pang, W. Boucher, C. Mompoint and B. Harrington. 1999. Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig. Dis. Sci. 44(S):87.
23. Wedemeyer J., M. Tsai and S.J. Galli. 2000. Roles of mast cells and basophils in innate and acquired immunity. Curr. Opin. Immunol. 12:624.
24. Marone G., S.J. Galli and Y. Kitamura. 2002. Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. Trends Immunol. 23:425.
25. Theoharides T.C. and D.E. Cochrane. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1.
26. Kempuraj D., S. Frydas, E. Karagouni, M. Hatzistilianou, P. Boscolo, F. Ferro, M. Di Giannantonio, C.M.V. Conti, D. Merlitti R. Doyle, C. Petrarca, M.L. Castellani and T.C. Theoharides. Cytokines and the brain. 2004. Int. J. Immunopathol. Pharmacol. 17:229.
27. Huang S.H., S. Frydas, P. Conti, D. Kempuraj, R.C. Barbacane, A. Grilli, W. Boucher, R. Letourneau, N. Papadopoulou and T.C. Theoharides. 2004. Interleukin-17: a revisited study. Int. J. Immunopathol. Pharmacol. 17:1.
28. Kempuraj D., B. Madhappan, R. Sheeladevi, M. Nazer, S. Christodoulou, J. Reginald, N. Suthinthirarajan and A. Namasivayam. 2004. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors. Int. J. Immunopathol. Pharmacol. 17:57.
29. Kempuraj D., S. Frydas, K. Kandere, B. Madhappan, R. Letourneau, S. Christodoulou, W. Boucher, G. Riccioni, P. Conti and T. C. Theoharides. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
30. Alexandrakis M.G., D.S. Kyriakou, D. Seretakis, W. Boucher, R. Letourneau, D. Kempuraj and T.C. Theoharides. 2003. Inhibitory effect of retinoic acid on proliferation, maturation and tryptase level in human leukemic mast cells (HMC-1). Int. J. Immunopathol. Pharmacol. 16:43.
31. Enerbäck L. 1965. Mast cells in carcinoid tumours. Distribution, histochemical properties and 5-hydroxytryptamine content. Acta Pathol. Microbiol. Scand. 64:491.
32. Kulke M.H. and R.J. Mayer. 1999. Carcinoid tumors. N. Engl. J. Med. 340:858.
33. Pothoulakis C., I. Castagliuolo and J.T. LaMont. 1998. Nerves and intestinal mast cells modulate responses to enterotoxins. News Physiol. Sci. 13:58.
34. Maurer M., T.C. Theoharides, R.D. Granstein, S.C. Bischoff, J. Bienenstock, B. Henz, P. Kovanen, A.M. Piliponsky, N. Kambe, H. Vliagoftis, F. Levi-Schaffer, M. Metz, Y. Miyachi, D. Befus, P. Forsythe, Y. Kitamura and S. Galli. 2003. What is the physiological function of mast cells? Exp. Dermatol. 12:886.
35. Hildebrandt U., K. Kessler, T. Plusczyk, G. Pistorius, B. Vollmar and M.D. Menger. 2003. Comparison of surgical stress between laparoscopic and open colonic resections. Surg. Endosc. 17:242.
36. Theoharides T.C., J.M. Donelan, N. Papadopireloire, J. Cao, D. Kempurayn and P. Conti. 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25:563.
37. Kempuraj D., M. Huang, K. Kandere-Grzybowska, S. Basu, W. Boucher, R. Letourneau, A. Athanasiou and T.C. Theoharides. 2003. Azelastine inhibits secretion of IL-6, TNF-α and IL-8 as well as NF-κB activation and intracellular calcium ion levels in normal human mast cells. Int. Arch. Allergy. Immunol. 132:231.
38. Middleton E., Jr., C. Kandaswami and T.C. Theoharides. 2000. The effects of plant flavonoids on mammalian cells:implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52:673.
39. Theoharides T.C., M. Alexandrakis, D. Kempuray and M. Lytinas. 2001. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int J. Immonopathol. Pharmacol. 14:119.